Your browser doesn't support javascript.
loading
Metformin versus SGLT-2 inhibitors: how low can we go?
Pruijm, Menno; Phan, Olivier; Zanchi, Anne.
Afiliação
  • Pruijm M; Service of Nephrology and Hypertension, Lausanne University Hospital and University of Lausanne, Department of Medicine, Lausanne, Switzerland. Electronic address: menno.pruijm@chuv.ch.
  • Phan O; Service of Nephrology and Hypertension, Lausanne University Hospital and University of Lausanne, Department of Medicine, Lausanne, Switzerland.
  • Zanchi A; Service of Nephrology and Hypertension, Lausanne University Hospital and University of Lausanne, Department of Medicine, Lausanne, Switzerland; Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Kidney Int ; 101(5): 874-877, 2022 05.
Article em En | MEDLINE | ID: mdl-35461613
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose / Metformina Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Inibidores do Transportador 2 de Sódio-Glicose / Metformina Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article